Ann Therese Olzinski-Kunze, M.D.View Contact & Scheduling
Dr. Olzinski-Kunze worked as an Attending Surgeon, Instructor of Surgery, and Assistant Professor of Surgery at Strong Memorial Hospital and Highland Hospital from 2004 to 2008. During this time, Dr. Olzinski-Kunze also served on the Strong Memorial Hospital Cancer Committee, from 2006 to 2008.
Now, after working in private practice for several years, Dr. Olzinski-Kunze is returning to UR Medicine. We are pleased to welcome her back to the Department of Surgery and the Wilmot Cancer Institute Comprehensive Breast Care at Pluta program.
Dr. Olzinski-Kunze is board certified by the American Board of Surgery. She is also a member of the American Society of Breast Surgeons. Dr. Olzinski-Kunze has been active in research and has authored and co-authored several publications.
Assistant Professor of Clinical Surgery (Part-Time) - Department of Surgery, Oncology (SMD)
Residency & Fellowship
Fellowship, Surgery (General Surgery), University of Rochester Medical Center. 2004 - 2004
Residency, Surgery (General Surgery), University of Rochester Medical Center. 2001 - 2004
Fellowship, Transplant Surgery, Medical College of Virginia Hospitals. 1999 - 2001
Residency, Surgery (General Surgery), Medical College of Virginia Hospitals. 1998 - 2000
Internship, Surgery (General Surgery), Medical College of Virginia Hospitals. 1997 - 1998
MD | University of Wisconsin-Madison. 1997
National Institute of Diabetes and Digestive and Kidney Diseases, National Research Service Award 1F32DK10025-01, Medical College of Virginia, 2000, Funding of research related to portal hypertension 2000
Lucille O'Keefe Parker Scholarship for academic excellence
University of Wisconsin Medical School 1996
Principal Investigator ACASOG Z0011: A Randomized Trial of Axillary Node Dissection in Women with T1 or T2 N0M0 Breast Cancer who have a Positive Sentinel...
Principal Investigator ACASOG Z0011: A Randomized Trial of Axillary Node Dissection in Women with T1 or T2 N0M0 Breast Cancer who have a Positive Sentinel Lymph Node- currently in follow up phase.
Principal Investigator ACOSOG Z0010: A Prognostic Study of Sentinel Node and Bone Marrow Micrometastases in Women with Clinical T1 or T2 N0M0 Breast Cancer: currently in follow up phase.
Co-Investigator NSABP B-39/RTOG 0413: Partial Breast Radiation for Patients with Stage 0, 1, or 2 Breast Cancer Resected by Lumpectomy- currently enrolling.
Co-Investigator ACOSOG Z1031: A Randomized Phase III Trial Comparing 16 to 18 Weeks of Neoadjuvant Exemestane, Letrozole, or Anastrozole in Postmenopausal Women with Clinical Stage II and III Estrogen Receptor Positive Breast Cancer- beginning enrollment in 2006.
Co-Investigator Evaluation of the Role of Heat Shock Protein 27 in Breast Cancer- enrolling beginning in 2006
Ratings & Reviews
At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.